Andrew Berchuck

Duke Medical Center

Papers

2

Total Citations

72

H-Index

2

About

Andrew Berchuck is a leading figure in gynecologic oncology, whose research has fundamentally shaped surgical practice for women with uterine and ovarian cancers. His work focuses on refining surgical staging and treatment, particularly through the adoption of sentinel lymph node (SLN) biopsy and minimally invasive techniques. A landmark study, cited over 50 times, demonstrated the feasibility and performance of SLN mapping in high-risk endometrial cancers, including grade 3 endometrioid, serous, and clear cell histologies. This work helped validate a less morbid alternative to complete lymphadenectomy for these aggressive tumors. Dr. Berchuck has also been a pioneer in surgical education, with influential publications on integrating robotic-assisted laparoscopic procedures into fellowship training programs. His contributions have not only advanced the standard of care but have also shaped how the next generation of surgeons is trained, ensuring that complex, minimally invasive techniques are safely and effectively disseminated. Through these efforts, Dr. Berchuck has left an indelible mark on the field, improving outcomes and quality of life for countless patients.

Research Focus

Key Achievements

2
H-Index
2
Papers
72
Total Citations
36
Avg Citations/Paper
🏆 Most Cited Paper
Performance of sentinel lymph node biopsy in high-risk endometrial cancer
54 citations · 2016
📈 Most Prolific Year: 2016 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Duke Medical Center

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago